LncRNA | MiRNA | Gene | Gene name | Pathway Name | Description | Title | Disease/Tissue | Journal | PubMed ID |
SNHG6-003 | miR-26a | AKT1 | AKT1;AKT;CWS6;PKB;PKB-ALPHA;PRKBA;RAC;RAC-ALPHA | details
Apoptosis;MAPK signaling pathway;Acute myeloid leukemia;ErbB signaling pathway;Chemokine signaling pathway;Fc gamma R-mediated phagocytosis;Insulin signaling pathway;Pathways in cancer;Melanoma;Dopaminergic synapse;Colorectal cancer;Estrogen signaling pathway;HTLV-I infection;Toll-like receptor signaling pathway;Glioma;Adipocytokine signaling pathway;HIF-1 signaling pathway;Jak-STAT signaling pathway;Proteoglycans in cancer;Toxoplasmosis;B cell receptor signaling pathway;Small cell lung cancer;Progesterone-mediated oocyte maturation;Non-small cell lung cancer;Measles;Fc epsilon RI signaling pathway;mTOR signaling pathway;PI3K-Akt signaling pathway;Chagas disease (American trypanosomiasis);Hepatitis C;VEGF signaling pathway;Prostate cancer;Renal cell carcinoma;Tuberculosis;Influenza A;T cell receptor signaling pathway;Osteoclast differentiation;Carbohydrate digestion and absorption; Endometrial cancer;Pancreatic cancer;Chronic myeloid leukemia;Cholinergic synapse;Hepatitis B;Focal adhesion;Epstein-Barr virus infection; Neurotrophin signaling pathway;Tight junction
|
details
Moreover, SNHG6-003 functioned as a competitive endogenous RNA (ceRNA), effectively becoming sponge for miR-26a/b and thereby modulating the expression of transforming growth factor-β-activated kinase 1 (TAK1).
|
details
The long non-coding RNA, SNHG6-003, functions as a competing endogenous RNA to promote the progression of hepatocellular carcinoma
|
Hepatocellular Carcinoma | ONCOGENE | 27530352 |
SNHG6-003 | miR-26b | AKT1 | AKT1;AKT;CWS6;PKB;PKB-ALPHA;PRKBA;RAC;RAC-ALPHA | details
Apoptosis;MAPK signaling pathway;Acute myeloid leukemia;ErbB signaling pathway;Chemokine signaling pathway;Fc gamma R-mediated phagocytosis;Insulin signaling pathway;Pathways in cancer;Melanoma;Dopaminergic synapse;Colorectal cancer;Estrogen signaling pathway;HTLV-I infection;Toll-like receptor signaling pathway;Glioma;Adipocytokine signaling pathway;HIF-1 signaling pathway;Jak-STAT signaling pathway;Proteoglycans in cancer;Toxoplasmosis;B cell receptor signaling pathway;Small cell lung cancer;Progesterone-mediated oocyte maturation;Non-small cell lung cancer;Measles;Fc epsilon RI signaling pathway;mTOR signaling pathway;PI3K-Akt signaling pathway;Chagas disease (American trypanosomiasis);Hepatitis C;VEGF signaling pathway;Prostate cancer;Renal cell carcinoma;Tuberculosis;Influenza A;T cell receptor signaling pathway;Osteoclast differentiation;Carbohydrate digestion and absorption; Endometrial cancer;Pancreatic cancer;Chronic myeloid leukemia;Cholinergic synapse;Hepatitis B;Focal adhesion;Epstein-Barr virus infection; Neurotrophin signaling pathway;Tight junction
|
details
Moreover, SNHG6-003 functioned as a competitive endogenous RNA (ceRNA), effectively becoming sponge for miR-26a/b and thereby modulating the expression of transforming growth factor-β-activated kinase 1 (TAK1).
|
details
The long non-coding RNA, SNHG6-003, functions as a competing endogenous RNA to promote the progression of hepatocellular carcinoma
|
Hepatocellular Carcinoma | ONCOGENE | 27530352 |